Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Shenzhen Esun Industrial Co. Ltd. is currently processing 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This matter is under the review of 1 distinct examiner, SHOMER, ISAAC, who is the busiest examiner with 1 busiest examiner pending action. The use of 1 distinct art unit indicates that the pending technology is specialized within the patent office's classification system.
As the company only has 1 pending office action, the prosecution strategy is entirely focused on the interaction with SHOMER, ISAAC. This streamlined approach allows for a dedicated response to the examiner's specific concerns but lacks the broader data points available to larger portfolios. The 1 distinct examiner's perspective will be the primary driver of the company's success in the Biotechnology & Pharmaceuticals sector.
The presence of 1 distinct art unit suggests a narrow technical focus for the company's current patenting efforts. With 1 busiest examiner pending action, the outcome of this single case is the top priority for the company's intellectual property management. Practitioners should analyze the specific tendencies of SHOMER, ISAAC to effectively navigate the prosecution of this single active application.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SHOMER, ISAAC | 1 | 63.1% | +30.3% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18430682 | PREPARATION METHOD AND APPLICATION METHOD OF INJECTABLE PLA MICROSPHERES | SHOMER, ISAAC | — |
| Art Unit | Apps |
|---|---|
| 1612 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18430682 | PREPARATION METHOD AND APPLICATION METHOD OF INJECTABLE PLA MICROSPHERES | SHOMER, ISAAC | 1612 | §112 | Final Rejection | — | Pending | Feb 02, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialShenzhen Esun Industrial Co. Ltd. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Isaac Shomer has the most, with 1 of Shenzhen Esun Industrial Co. Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.